AP
Insider
Anish Patel
CHIEF OPERATING OFFICERAnish Patel (CHIEF OPERATING OFFICER) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $1.3M of ELVN (48,057 sh × $27.98, as filed), executed Jan 9.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.7M
shares × price, as filed
Last traded
Jan 9
Filed Jan 13
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$113K6,173 sh × $18.30
Exec May 7 2025
Filed May 9 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $143K
6,667 sh × $21.44
Exec Mar 7 2025
Filed Mar 11 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $146K
6,667 sh × $21.93
Exec Feb 7 2025
Filed Feb 10 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $648K
26,837 sh across 2 lots
Exec Jan 7 2025
Filed Jan 10 2025 · 5:30 PM ET †